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Background: Syncope remains challenging for Emergency Department (ED) physicians due to difﬁculties in
assessing the risk of future adverse outcomes. The aim of this meta-analysis is to establish the incidence
and etiology of adverse outcomes as well as the predictors, in patients presenting with syncope to the ED.
Methods: A systematic electronic literature review was performed looking for eligible studies published be-
tween 1990 and 2010. Studies reporting multivariate predictors of adverse outcomes in patients presenting
with syncope to the ED were included and pooled, when appropriate, using a random-effect method. Adverse
events were deﬁned as ‘incidence of death, or of hospitalization and interventional procedures because of ar-
rhythmias, ischemic heart disease or valvular heart disease’.
Results: 11 studies were included. Pooled analysis showed 42% (CI 95%; 32–52) of patients were admitted to
hospital. Risk of death was 4.4% (CI 95%; 3.1–5.1) and 1.1% (CI 95%; 0.7–1.5) had a cardiovascular etiology.
One third of patients were discharged without a diagnosis, while the most frequent diagnosis was ‘situational,
orthostatic or vasavagal syncope’ in 29% (CI 95%; 12–47). 10.4% (CI 95%; 7.8–16)was diagnosedwith heart dis-
ease, themost frequent type being bradyarrhythmia, 4.8% (CI 95%; 2.2–6.4) and tachyarrhythmia 2.6% (CI 95%;
1.1–3.1). Palpitations preceding syncope, exertional syncope, a history consistent of heart failure or ischemic
heart disease, and evidence of bleeding were the most powerful predictors of an adverse outcome.
Conclusion: Syncope carries a high risk of death, mainly related to cardiovascular disease. This large study
which has established the most powerful predictors of adverse outcomes, may enable care and resources
to be better focused at high risk patients.© 2011 Elsevier Ireland Ltd. All rights reserved.1. Introduction
Syncope is a common clinical presentation accounting for up to 3%
of all Emergency Department (ED) visits and 6% of hospital admissions
[1]. Accurate diagnosis and assessment of prognosis [2]are required by
ED physicians, as syncope may be due to a wide range of possible
etiologies ranging from benign conditions to life-threatening diseasesision of Cardiology, University
Bramante 88-90, 10126 Turin,
scenzo).
Ltd. All rights reserved.[3,4]. Focused inpatient investigation concentrating on high risk
patients may save some of the 2 billion dollars spent every year in
the United States of America on the hospitalization of patients with
syncope [5,6].
Several clinical decision rules (CDRs) and risk stratiﬁcation scores
have been derived to help physicians with diagnosis and risk assess-
ment. These have performed less well when validated and applied to
everyday clinical practice [7], possibly due to relatively small numbers
of patients in each.
To our knowledge, nometa-analyses have been performed looking
at either the short or long term diagnosis and prognosis of syncope
and its most powerful predictors. The aim of this study is therefore
to establish the incidence and etiology of adverse outcomes as well
Table 1
Key features of included studies.
Studies N=11
Study design
Prospective cohort
Retrospective cohort
8 (70%)
3 (30%)
Data source
Clinical database 11 (100%)
Years of publication 2004–2009
Setting
Single center
Multicenter
5 (45%)
6 (55%)
Location
North America
Europe
Asia
5 (45%)
5 (45%)
1 (10%)
Total patients presenting with syncope to the
Emergency Department
Median number of patients per study (1st–3rd quartile)
43,315
670 (487–913)
Follow-up in months (median; 1st–3rd quartile) 1 (1–16)
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order to offer physicians a more robust future assessment of risk.
2. Methods
The present research was conducted following current guidelines, including the
recent Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA)
amendment to the Quality of Reporting of Meta-analyses (QUOROM) statement, and
recommendations from The Cochrane Collaboration andMeta-analysis Of Observation-
al Studies in Epidemiology (MOOSE) [8–11].
2.1. Search strategy and study selection
Possible articles for inclusion were found using established search methods [12]
looking for the terms “syncope”, “multivariate predictors” and “adverse outcomes”.
The corresponding authors of possible studies were then directly contacted via email
asking for further data and knowledge of further studies [13].
Two independent reviewers (GB-Z, FDA) initially screened all possible articles for
inclusion at the title and/or abstract level, with disagreement resolved by consensus.
If thought potentially eligible, the complete article was then reviewed according to
the following strict selection criteria. Studies had to be both (i) investigating patients
presenting to the ED with syncope AND (ii) reporting predictors of adverse outcomes
after syncope using multivariate analysis methodology. Exclusion criteria were any of:
(i) non-human study, (ii) duplicate reporting (in which case the manuscript reporting
the largest sample of patients was selected) or (iii) differentiated syncope patients (i.e.
studies recruiting patients with an already deﬁned diagnosis of syncope e.g. cardiovas-
cular cause only).
2.2. Data extraction
Two unblinded independent reviewers (GB-Z, FDA) abstracted the following data
on pre-speciﬁed data collection forms: authors, journal, year of publication, location
of the study group, baseline features, admission and death rates, inclusion and exclu-
sion criteria, ﬁnal identiﬁed cause of syncope (if any), multivariate predictors of adverse
outcomes (point summary estimate of risk, with 95% conﬁdence interval). Pre-deﬁned
end-points were incidence of in-hospital admission, incidence of adverse outcomes
(deﬁned as incidence of death, or of hospitalization and interventional procedures be-
cause of arrhythmias, ischemic heart disease or valvular heart disease') and ﬁnal iden-
tiﬁed cause of syncope (if any).
2.3. Internal validity and quality appraisal
Unblinded independent reviewers (GB-Z, FDA) evaluated the quality of the select-
ed studies on pre-speciﬁed data collection forms using modiﬁed MOOSE criteria to take
into account the speciﬁc features of included studies [10]. The independent reviewers
separately appraised study design, setting, data source, and statistical methods for
multivariable analysis, as well as risk of analytical, selection, adjudication, detection,
and attrition bias (expressed as low, moderate, or high risk of bias). Where present, in-
complete reporting leading to inability to ascertain the underlying risk of bias was also
recorded. All studies then received an overall score based as follows: Zero points were
awarded for a retrospective design or single center study; One point for prospective
design and/or multicenter setting; Two points were awarded for low risk of bias, one
point for moderate risk of bias, and zero points for high risk or unclear risk of bias. If
the total of these scores was 10 an overall ‘very high’ credibility rating was awarded,
if the total was between 7 and 9 a ‘high’ credibility rating was awarded, if the total
was between 4 and 6 a ‘moderate’ credibility rating was awarded, if the total was be-
tween 1 and 3, a ‘low’ credibility rating was awarded and for a total score of 0, a ‘very
low’ credibility rating was awarded (see Appendix Table B).198 citations identified from 
database search
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obtaine
17 full text articles appra
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11 studies finally include
the systematic review
Fig. 1. Study ﬂo2.4. Data analysis
Continuous variables are reported asmean (standard deviation) ormedian (range).
Categorical variables are expressed as n/N (%). Statistical pooling was performed
according to a random-effect model with generic inverse-variance weighting, comput-
ing risk estimates with 95% conﬁdence intervals, using RevMan 5 (The Cochrane Collab-
oration, The Nordic Cochrane Centre, and Copenhagen, Denmark). Graphical inspection
of funnel plots was used to assess for study bias. Standard hypothesis testing was set at
the two-tailed 0.05 level.
3. Results
201 citations were initially screened of which 17 reports were
fully evaluated for consideration in the study. Three reports were
excluded as they were non-ED studies [14–16], two were excluded
because they reported differentiated patients with a pre-deﬁned
diagnosis of syncope (in both cases syncope patients with a diagnosis
of cardiovascular syncope) [17,18], one was excluded because it did
not report multivariate predictors [2], and one study was excluded
because of duplicate reporting [19]. 11 studies were ﬁnally included
in the meta-analysis [20–30] (Fig. 1).
The main features of the included studies are reported in Table 1.
Most of the studies were prospective, multicenter, with a median of
670 patients and a follow up of 1 month. While syncope was variably
deﬁned, all included papers essentially deﬁned syncope according to
the European Society of Cardiology 2009 guidelines (Table 2) [32].
Appendix Table B details the methodological validity of the 11 in-
cluded studies. Logistic regression was the most frequent multivariate
approach, with most of the studies reporting an overall high credibi-
lity. The main limitations were in adjudication and attrition bias.ditional citations 
d from other sources
ised 
teria
d in 
3 excluded because not 
investigating patients 
admitted to E.D;
2 because of patients with an 
already defined diagnosis of 
syncope;
1 because of duplicate 
reporting;
1 because not reporting 
multivariate predictors
w diagram.
Table 2
Inclusion and exclusion criteria of included studies.
Author, journal, year Inclusion criteria Exclusion criteria
OH, Arch Inter Med, 1999 Sudden transient loss of consciousness (LOC)
with an inability to maintain postural tone.
Symptoms compatible with seizure disorder, vertigo, dizziness, coma, shock,
or other states of altered consciousness.
Colivicchi, EHJ, 2003 Sudden and transient LOC and of postural tone
with spontaneous recovery.
Pre-syncope, dizziness or vertigo, without a clear loss of consciousness or
already known seizure disorder and presenting a typical recurrence, with
prolonged post-ictal recovery phase.
Sarasin, Acad Emer Med, 2003 Sudden transient LOC with an inability to maintain
postural tone, and with spontaneous recovery.
Symptoms clearly compatible with seizure disorder, vertigo, dizziness, coma,
shock, or other states of altered consciousness.
Suzuki, Ann Emerg Med, 2003 Sudden transient LOC with an inability to maintain
postural tone.
Seizure, vertigo, dizziness, coma, shock, or other altered states of consciousness.
Quinn, Ann Inter Med, 2004 Sudden transient LOC. Altered mental status, alcohol or illicit drug-related loss of consciousness,
a deﬁnite seizure, or transient loss of consciousness caused by head trauma.
Sun, J Am Geriatr Soc, 2007 Sudden transient LOC. Witnessed seizure, loss of consciousness after head trauma, ongoing
confusion (including baseline cognitive impairment or dementia),
intoxication, age younger than 18, inability to speak English or Spanish,
do-not-resuscitate (DNR) or do-not-intubate (DNI) status, and lack of
follow-up contact information.
Costantino, JACC, 2008 Sudden transient LOC. Presence of clinical conditions primarily conﬁrmed in the ED that would have
required hospital admission independently of the syncope such as myocardial
infarction, acute pulmonary embolism, subarachnoid hemorrhage, stroke,
cardiac arrest, sustained bradycardia (35 beats/min), complete atrioventricular
block, sustained ventricular tachycardia; a referred head injury preceding the
loss of consciousness; a referred non-spontaneous return to consciousness;
non-syncopal syndromes such as light-headedness, vertigo, coma, shock, and
seizure; associated diseases with a prognosis less than 6 months; recent
alcohol or drug abuse; unwillingness to provide consent to participate in the
study; and unfeasible follow-up (foreigners, homeless).
Del Rosso, BMJ, 2008 Sudden transient LOC. Deﬁnite non-syncopal cause of loss of consciousness on the initial evaluation
(seizures, drop attacks, transient ischemic attacks, etc.), those aged, 18 years
and those referred 24 h after their episode.
Sun, Ann Emerg Med, 2009 Sudden, transient loss of consciousness, and
near-syncope as a sensation of imminent loss
of consciousness.
Generalized seizure, intoxication, no spontaneous return to baseline mental
status and patients who experienced loss of consciousness as a result of
head trauma.
Gabayan, AJC, 2010 Blackout, fainting (near), syncope, vasovagal attack. Carotid sinus syncope, heat syncope, neurocirculatory asthenia, orthostatic
hypotension, shock.
Reed, JACC, 2010 Sudden transient LOC with an inability to maintain
postural tone.
Persisting neurological deﬁcit suggestive of stroke, previous recruitment into
the study, collapse related to alcohol consumption (raised alcometer reading
and no other cause for syncope), hypoglycemia, trauma, or seizure activity
with a less 15-min witness reported postictal phase.
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reporting in 38% a history of previous syncope, and in 30% a history
of previous heart disease, most frequently arrhythmic (11%) or ische-
mic heart disease (8%) (Table 3).
Pooled analysis of outcomes and diagnosis of all included patients
are reported in Tables 4 and 5. At a median follow-up of 1 month,
risk of death was 4.4%, which was due to a cardiovascular etiology in
1.1%. 42% of patients were admitted to hospital: 10.4% of patients
were diagnosed with heart disease; the most frequent causes were
bradyarrhythmic (4.8%) and tachyarrhythmic disease (2.6%). 29% of
patients were discharged without a diagnosis and the most frequent
diagnosis was situational, orthostatic or vasavagal syncope (29%).Table 3
Key patient characteristics.
Studies N=11
Age (years) 63 (60–64)
Male gender 45% (41–60)
Diabetes 12% (6–13)
Hypertension 39% (35–43)
History of previous syncope 38% (32–44)
History of heart disease 30% (24–49)
History of arrhythmic heart disease 11% (4–19)
History of ischemic heart disease 8% (6–26)
History of heart failure 8% (2–9)
History of valvular disease 1% (0.2–4)
History of ischemic neurological disease. 15% (8–21)
Reported as n (%) or median (1st–3rd quartile).The most powerful predictors of adverse outcome (Table 6 and
Fig. 2) were palpitations preceding syncope, syncope during effort, a
history consistent of heart failure or ischemic heart disease and clini-
cal and laboratory evidence of bleeding.
4. Discussion
The most important ﬁndings of our meta-analysis are (a) patients
presenting with syncope to the ED carry a low although signiﬁcant
risk of death, (b) one third of deaths are ascribable to cardiovascular
diseases, (c) a large proportion of patients are still discharged without
a clear diagnosis and (d) simple predictors could be useful to identify
high risk patients.Table 4
Pooled analysis of syncope etiology.
Diagnosis of cardiovascular disease
– Rhythmic disease
– Bradyarrhythmic disease
– Tachiarrhythmic disease
– Myocardial infarction
– Aortic stenosis
10.4% (8–16)
7.4% (4.5–10)
2.6% (1.1–3.1)
4.8% (2.2–6.4)
1.7% (1–2.4)
1.3% (0.7–2.1)
Diagnosis of stroke 0.8% (0.5–0.9)
Diagnosis of situational, orthostatic or vasovagal syncope 29% (9–49)
Diagnosis of pulmonary embolus 0.6% (0.2–0.96)
Diagnosis of gastrointestinal bleeding/anemia 2.4% (1.5–3.3)
Diagnosis of unexplained syncope 29.6% (11–47)
Reported as% (95% CI).
Table 5
Pooled analysis of patient's management and of adverse outcomes.
Studies N=11
Patients discharged to home 58% (48–68)
Patients admitted to hospital 42% (32–52)
Overall death 4.4%a (3.1–5.1)
Cardiovascular related death 1.1% (0.7–1.5)
Non cardiovascular related death 1.5% (0.7–2.4)
Unexplained death 1.7% (0.2–3.3)
Reported as% (95% CI).
a Overall death was 4.36% made up of cardiovascular death (1.1%), non-
cardiovascular death (1.5%) and unexplained death (1.73%).
Table 6
Most common predictors of adverse outcomea after a syncopal episode identiﬁed in in-
cluded studies.
Studies N=11 (%)
Previous heart diseaseb 11 (100)
Abnormal Electrocardiogram (ECG)c 11 (100)
Age (per 10 year increase) 6 (45)
Abnormal values of blood pressure (b90 mm Hg, or >160 mm Hg) 3 (27)
Male gender 3 (27)
Clinical or laboratory evidence of bleedingd 2 (18)
The following predictors were reported only in one study each:
>4 episodes of syncope in the last year;
Absence of symptoms preceding syncope;
Abnormal B natriuretic peptide concentration;
Prior cerebrovascular disease or heart disease;
Cancer;
Palpitations preceding syncope;
Syncope while supine,
Syncope during effort or without prodrome,
Trauma;
Abnormal troponin value.
a Incidence of death, or of hospitalization and interventional procedures be-
cause of arrhythmias, ischemic heart disease or valvular heart disease.
b Previous heart failure or ischemic heart disease.
c Widely deﬁned as Rhythm abnormalities, Atrioventricular or intraventricular
conduction disorders and ST segment and T wave abnormalities consistent with
or possibly related to myocardial ischemia.
d Diagnosed via complete/full blood count or rectal examination.
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face in the ED or on a hospital ward. Emergency physicians take
care of the initial management of patients, while further assessment
of patients involves cardiologists and neurologists [32,33]. The diag-
nosis is often difﬁcult due to many possible underlying causes [7],
and because usually patients are totally asymptomatic during medical
evaluation [20]. As seen from our data, all hospitalized patients still
carry a signiﬁcant risk of death, mainly related to cardiovascular
causes, which persists, as previously showed, at long term [2].
In this study, syncope was thought to be due to situational, ortho-
static or vasavagal causes [17] in up to one third of cases but still in
one third of cases the etiology of syncope was not clear. Patients
with situational syncope are not at risk of death or of adverse out-
come and can be managed generally with lifestyle changes [7]. On
the other hand unexplained syncope can have adverse outcome,
and usually involves older and sicker patients [31].
Simple predictors of adverse outcomes could be very useful to
identify high risk patients. In our meta-analysis, palpitations preced-
ing syncope, syncope during effort, history of heart failure or ischemic
heart disease and clinical and laboratory evidence or bleeding are the
most powerful predictors of adverse outcome, while the most fre-
quent to appear in the included studies are a history of heart disease
and an abnormal electrocardiogram (ECG). Most of these factors are
easy to assess, both through basic history and physical examination,
and could improve diagnostic and therapeutic decision making
(Table 6).Fig. 2. Most powerful predictors of adverse outcome+ after syncope (those with an OR>5
arrhythmias, ischemic heart disease or valvular heart disease'.* History consistent with hea
examination.This work has many limitations. Firstly adverse outcomes were in-
frequent, thus leading to potential pitfalls in an accurate reporting
[34]. Secondly, predictors were not pooled, mainly because this
would have been fraught with a substantial selective reporting bias
[35]. Because the present meta-analysis was based only on published
studies, publication bias may be a problem, although small study bias
was unapparent at funnel plot inspection (Fig. A, Appendix). Another
weakness of our work was not performing an individual patient level
meta-analysis. This could have provided more detailed information
on incidence and predictors, but most likely would have required
exclusion of several datasets thus limiting the study's external
validity.).+ Incidence of death, or of hospitalization and interventional procedures because of
rt failure or ischemic heart disease.** Diagnosed via complete/full blood count or rectal
Fig. A. Funnel plot.
Studies N=11
Multivariate analysis approach
Logistic regression
Cox proportional hazard models
Recursive partitioning
8 (73%)
2 (18%)
1 (9%)
Analytical bias
Low risk
Moderate risk
6 (55%)
5 (45%)
Selection bias
Low risk
Moderate risk
7 (63%)
4 (37%)
Adjudication bias
Low risk
Moderate risk
7 (63%)
4 (37%)
Attrition bias
Low risk
Moderate risk
5 (45%)
6 (55%)
Overall credibility
Moderate
High
3 (27%)
8 (73%)
61F. D'Ascenzo et al. / International Journal of Cardiology 167 (2013) 57–62Because our study pooled smaller studies, it provides better data
on more frequent syncope causes but does not provide any informa-
tion on rarer causes such as short and long QT syndromes, or Brugada
syndrome which may be expected to appear rarely in a study on
43 thousand patients [36,37].
Syncope carries a high risk of death, mainly related to cardiovas-
cular disease. This large study which has established the most power-
ful predictors of adverse outcome may enable care and resources to
be better focused at high risk patients. Future efforts should be fo-
cused on standardizing reporting criteria for ED syncope studies to
allow better pooling of results from different centers.Acknowledgments
Thanks to Alberto Milan for his outstanding support. The authors
of this manuscript have certiﬁed that they comply with the Principles
of Ethical Publishing in the International Journal of Cardiology.Appendix Table A. Assessment of biasBias Risk of bias
Analytical bias
– Analysis being performed from different physicians or statistics
– Analysis being performed by single physician or statistic
Low risk
Medium risk
Selection bias
– Including all consecutive patients with syncope
– Excluding patients not because of clinical choices
(for ex. those unavailable for follow-up)
– Excluding patients who commonly refer to ED for syncope
Low risk
Medium risk
High risk
Adjudication bias
– Independent committee who critically reviewed outcomes
– Follow up visits performed in hospital or ambulatories
– Follow up phone calls
– There may be a risk of bias, but there is either insufﬁcient
information to assess whether an important risk of bias exists;
or insufﬁcient rationale or evidence that an identiﬁed problem
will introduce bias.
Low risk
Medium risk
High risk
Unclear
Attrition bias
– 100% of patients with a complete follow-up
– Less than 100% of patients completed follow-up—There may
be a risk of bias, but there is either insufﬁcient information to
assess whether an important risk of bias exists; or insufﬁcient
rationale or evidence that an identiﬁed problem will introduce
bias.
Low
Medium
UnclearAppendix Table B. Internal validity of included studiesReferences
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